Lithium remains a first-line approach for the treatment of acute mania
and the prophylactic management of manic-depressive illness, yet the
underlying neurobiological mechanisms remain as yet undefined. In this
paper we critically examine the accumulated preclinical and clinical
evidence for the action of lithium in the brain and suggest areas that
may be most productive for future investigation, i.e., membrane trans
port systems, neurotransmitter receptor regulation, second messenger g
enerating systems, protein kinase C (PKC) regulation, and gene express
ion. In their experimental design, preclinical investigations have oft
en jeopardized the physiologic relevance of their studies by a relativ
e lack of attention to issues such as therapeutic concentrations, acut
e versus chronic exposure, and a lack of adequate cation and/or psycho
tropic controls. Future studies should account for the established pro
phylactic efficacy of lithium, the higher risk for relapse into mania
after abrupt discontinuation, the ability of lithium to stabilize recu
rrent depression associated with unipolar disorder? and the efficacy o
f lithium in the treatment of refractory major depressive disorder in
the presence of an antidepressant. Studies of the action of lithium in
receptor mediated phosphoinositide signaling in the brain over the pa
st several years have opened up heuristic lines of investigation that
stem from lithium's uncompetitive inhibition of the enzyme inositol mo
nophosphatase. Subsequent studies involving regulation of inositol tra
nsport, PKC isozymes and activity, and the expression of the major PKC
substrate MARCKS (myristoylated alanine-rich C-kinase substrate) have
offered potential avenues for understanding the complexity of the act
ion of long-term lithium in the brain. These studies will offer us a b
etter understanding of the neuroanatomical sites of action of lithium
and together with ongoing clinical investigations using brain imaging
in patients with manic-depressive illness a more complete understandin
g of the pathophysiology of this disease.